{"nctId":"NCT02655653","briefTitle":"Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery","startDateStruct":{"date":"2008-10"},"conditions":["Bleeding"],"count":114,"armGroups":[{"label":"Epsilon-aminocaproic acid (EACA)","type":"EXPERIMENTAL","interventionNames":["Drug: Epsilon-aminocaproic acid administered"]},{"label":"Tranexamic acid (TA)","type":"EXPERIMENTAL","interventionNames":["Drug: Tranexamic Acid administered"]}],"interventions":[{"name":"Epsilon-aminocaproic acid administered","otherNames":[]},{"name":"Tranexamic Acid administered","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Informed consent obtained before any trial-related activities\n* Subjects scheduled to undergo cardiac surgery requiring cardiopulmonary bypass\n\nExclusion Criteria:\n\n* Vulnerable patient populations (unable to consent)\n* Religious or other prohibitive reason for not receiving blood transfusion\n* History of allergy to epsilon-aminocaproic acid or tranexamic acid\n* Pregnant or breast-feeding (if applicable)\n* The participation in another clinical or device trial that would affect the patient's coagulation profile\n* Cardiac or cardiopulmonary transplantation procedure\n* Any history of stroke and/or non-coronary thrombotic disorders (DVT, PE)\n* Clinical signs consistent with non-coronary thrombotic disease\n* Known congenital deficiency of Protein C, Protein S, Antithrombin and homozygous Factor V Leiden\n* Known congenital bleeding disorders\n* Weight \\< 50 kg\n* Weight \\> 150 kg\n* Acute renal failure or creatinine \\> 2.0 mg/dL\n* Current surgery including any implantable ventricular assist device requiring CPB including ECMO (extracorpeal membrane oxygenation)\n* Current surgery including the aortic arch and/or descending thoracic aorta\n* Any changes to the planned surgery, which result int he patient not requiring CPB or meeting exclusion criteria","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Chest Tube Drainage","description":"Chest tube drainage are collected from the nursing records, every 4th hourly the amount fluid collected is reported in the collection sheets.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"200","spread":"375"},{"groupId":"OG001","value":"225","spread":"400"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"375","spread":"550"},{"groupId":"OG001","value":"400","spread":"675"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"425","spread":"750"},{"groupId":"OG001","value":"500","spread":"825"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"700","spread":"1100"},{"groupId":"OG001","value":"800","spread":"1225"}]}]}]},{"type":"PRIMARY","title":"Median Amount of Blood Products Used","description":"Four types of blood products may be given through blood transfusions: whole blood, red blood cells, platelets, and plasma","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":".59","spread":"1.3"},{"groupId":"OG001","value":"1.20","spread":"2.2"}]}]}]},{"type":"SECONDARY","title":"Diagnosis of Renal Dysfunction Post-operation","description":"Confirmed diagnosis of renal dysfunction and hospitalization for the same within 30 days after the surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Diagnosis of Myocardial Infarction Post-operation","description":"Confirmed diagnosis of myocardial infraction and hospitalization for the same within 30 days after the surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Have Confirmed Diagnosis of Respiratory Arrest","description":"Confirmed diagnosis of respiratory arrest and hospitalization for the same within 30 days after the surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Confirmed Diagnosis of Stroke","description":"Confirmed diagnosis of stroke and hospitalization for the same within 30 days after the surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Confirmed Diagnosis of Seizure","description":"Confirmed diagnosis of seizure and hospitalization for the same within 30 days after the surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Reoperation","description":"Confirmed diagnosis of reopeartion and hospitalization for the same within 30 days after the surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Mortality Within 30 Days Post-operation","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Patient Demographics","description":"Measurements taken as a composite. BMI, Sex, Age are to be determined to ensure that the subjects' characteristics were comparable between the Epsilon-aminocaproic Acid and Tranexamic Acid groups.","classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Type of Surgery","description":null,"classes":[]},{"type":"OTHER_PRE_SPECIFIED","title":"Intraoperative Characteristics","description":"Measurements are taken as a composite to determine that the subjects' characteristics are comparable between the Epsilon-aminocaproic Acid and Tranexamic Acid groups. Measurements include temperature, Heparin dose, protamine given, time of surgery, time of cardiopulmonary bypass, and aortic clamp time.","classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":20,"n":56},"commonTop":[]}}}